DUNTON ALAN W
SEC Form 4 insider trading activity
DUNTON ALAN W has filed 3 SEC Form 4 filings (6 transaction rows) across 2 companies, including CRMD, PTN, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Jan 2, 2026.
On the most recent filing, DUNTON ALAN W is listed as Director at CorMedix Inc. Inside the rolling window, DUNTON ALAN W reported no open-market purchases and 1 open-market sale totaling $260K in CRMD.
Companies traded
Other insiders at CRMD
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$260K
reported sales (SEC code S)
Companies
2
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Sep 12, 2025 | CRMD | Sale | $131K |
Frequently asked questions
How many SEC Form 4 filings has DUNTON ALAN W made?
DUNTON ALAN W has filed 3 SEC Form 4 filings (6 transaction rows) across 2 companies, including CRMD, PTN since 2025.
Which companies does DUNTON ALAN W trade?
DUNTON ALAN W has filed SEC Form 4 disclosures for 2 companies, including CRMD, PTN.
When was DUNTON ALAN W's most recent SEC Form 4 filing?
DUNTON ALAN W's most recent SEC Form 4 filing on Tracefour is dated Jan 2, 2026.
What is DUNTON ALAN W's total buy and sell value in the current window?
Inside the rolling retention window, DUNTON ALAN W bought $0 and sold $260K based on SEC Form 4 filings.
What was DUNTON ALAN W's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 20,000 CRMD shares on 2025-12-30, worth $260K, per SEC Form 4 filings.